Families with SMA babies hope for miracle cure

February 16, 2021 09:46 pm | Updated 09:46 pm IST - Bengaluru

Parents of babies with Spinal Muscular Atrophy (SMA), a rare genetic disease, came together at an event organised by Bangalore Baptist Hospital in the city on Tuesday.

Raman Gowda and Beembai, parents of one-year-old Aadhya, said they are waiting for some miracle cure for their baby. Another family came down from Chennai to discuss their 3.5-year-old daughter Rudra’s daily progress with the doctor.

SMA is a disease caused by loss of nerve cells, which carry electrical signals from the brain to the muscles. The disease, as it progresses, makes it extremely difficult for the babies to carry out basic activities like sitting up, lifting their head, swallowing milk and even breathing.

The hospital has a dedicated Paediatric Neuromuscular Service, a pioneering centre in the country with a multidisciplinary team of doctors providing comprehensive care under one roof. This service is run in collaboration with Organisation for Rare Diseases India, a NGO.

A gene therapy costing ₹16 crore is the only shot of life for nearly 200 children under the care of specialists here. Last month, the gene therapy called Zolgensma, was offered free to 14-month-old baby Fatima from Bhatkal who was the lucky winner of a lottery through a compassionate access programme by Novartis, the Swiss drugmaker.

While baby Fatima was lucky, several other babies are waiting for the miracle cure. “We have registered five more children for the lottery. While one family has resorted to crowdfunding, others are desperately waiting for the expensive therapy,” said Ann Agnes Mathew, Consultant Paediatric Neurologist and Neuromascular Specialist at the hospital.

Speaking at the event, State Health Director Om Prakash Patil said the Union Ministry is working on a special programme for children with rare diseases. “We already had two-three meetings in this regard,” he said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.